Aescap Venture
Aescap Life Sciences and Aescap Genetics funds invest in innovative, publicly traded biotech/life sciences companies developing next-gen medicines. Focused portfolios, deep fundamental analysis, and SFDR Article 8 compliance. Targets medium-term returns with disciplined risk management.
Funding Stage: Series A/B, Series C & Beyond
Investor type: VC Firm
Investment Areas: Biotechnology, CleanTech, Venture Capital, Life sciences, Fund management
Country: Netherlands
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.